|
Market Closed -
NSE India S.E.
09:05:07 28/08/26 pm AEST
|
5-day change | 1st Jan Change | ||
| 2,515.00 INR | +2.24% |
|
+8.50% | +23.58% |
| Market Cap | 710B 7.43B 6.4B 6B 5.48B 10.32B 10.35B 71.18B 27.77B 358B 27.88B 27.27B 1,188B | P/E 2027 * |
30.6x | P/E 2028 * | 25.4x |
|---|---|---|---|---|---|
| Enterprise Value | 673B 7.04B 6.07B 5.69B 5.2B 9.79B 9.82B 67.52B 26.34B 340B 26.45B 25.87B 1,127B | EV / Sales 2027 * |
4.01x | EV / Sales 2028 * | 3.54x |
| Free-Float |
51.04% | Yield 2027 * |
0.15% | Yield 2028 * | 0.16% |
Last Transcript : Glenmark Pharmaceuticals Limited
| 1 day | +2.24% | ||
| 1 week | +8.50% | ||
| Current month | +12.58% | ||
| 1 month | +15.12% | ||
| 3 months | +5.46% | ||
| 6 months | +17.70% | ||
| Current year | +23.58% |
| 1 week | 2,295.3 |  | 2,537.6 |
| 1 month | 2,162 | | 2,537.6 |
| Current year | 1,842 | | 2,537.6 |
| 1 year | 1,792.6 | | 2,537.6 |
| 3 years | 722.1 | | 2,537.6 |
| 5 years | 348.5 | | 2,537.6 |
| 10 years | 161.65 | | 2,537.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 86 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.24% | +8.50% | +29.85% | +227.84% | 7.43B | |
| +0.35% | +0.93% | +21.08% | +71.89% | 48.2B | |
| -0.08% | -0.21% | +55.27% | +121.68% | 39.97B | |
| +0.15% | +6.34% | +21.70% | +87.77% | 12.43B | |
| +0.25% | -0.61% | -9.92% | +15.84% | 12.03B | |
| +0.19% | 0.00% | +30.00% | +147.62% | 9.35B | |
| +0.07% | +3.80% | +27.45% | +46.12% | 7.75B | |
| +0.04% | +0.37% | +48.15% | -11.95% | 7.22B | |
| -0.53% | -1.53% | -34.29% | +19.67% | 5.3B | |
| +0.38% | -2.27% | +41.81% | +106.26% | 4.65B | |
| Average | +0.31% | +1.86% | +23.11% | +83.27% | 15.43B | |
| Weighted average by Cap. | +0.24% | +1.31% | +28.84% | +87.81% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 168B 1.76B 1.51B 1.42B 1.3B 2.44B 2.45B 16.84B 6.57B 84.77B 6.6B 6.45B 281B | 187B 1.96B 1.69B 1.58B 1.44B 2.72B 2.73B 18.77B 7.32B 94.46B 7.35B 7.19B 313B |
| Net income | 23.11B 242M 208M 195M 178M 336M 337M 2.32B 904M 11.67B 908M 888M 38.68B | 27.71B 290M 250M 234M 214M 403M 404M 2.78B 1.08B 13.99B 1.09B 1.06B 46.38B |
| Net Debt | -36.49B -382M -329M -308M -282M -530M -532M -3.66B -1.43B -18.42B -1.43B -1.4B -61.08B | -48B -502M -433M -406M -370M -698M -700M -4.81B -1.88B -24.23B -1.89B -1.84B -80.35B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | INR 2,515.00 | +2.24% | 807,816 |
| 27/08/26 | INR 2,460.00 | +0.89% | 447,011 |
| 26/08/26 | INR 2,438.30 | +1.60% | 479,931 |
| 25/08/26 | INR 2,400.00 | +0.39% | 653,245 |
| 24/08/26 | INR 2,390.70 | +3.14% | 710,023 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
